The Biden Administration won’t need any new coronavirus vaccines approved by the FDA to fulfill its plan to purchase 200 million additional doses by the summer.
Watch the briefing stream in the video player above.
White House press secretary Jen Psaki says while it’s a “positive step” for additional vaccines to receive FDA approval, the Biden Administration will rely solely on Moderna and Pfizer for its new purchases.
Johnson & Johnson announced Friday its single-dose coronavirus vaccine was effective, though at a lower rate than the Moderna and Pfizer vaccines. The company is seeking emergency-use authorization from the FDA.
Psaki says the Biden administration would “rely on our health and medical experts to advise” on additional vaccines.
Psaki also spoke about the push for a relief package from Congress and the hope that bipartisan support will be a part of it.